A detailed history of Santori & Peters, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Santori & Peters, Inc. holds 1,961 shares of AMGN stock, worth $612,714. This represents 0.24% of its overall portfolio holdings.

Number of Shares
1,961
Previous 1,946 0.77%
Holding current value
$612,714
Previous $560,000 0.54%
% of portfolio
0.24%
Previous 0.27%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

BUY
$268.87 - $324.56 $4,033 - $4,868
15 Added 0.77%
1,961 $557,000
Q4 2023

Feb 05, 2024

BUY
$255.7 - $288.46 $3,579 - $4,038
14 Added 0.72%
1,946 $560,000
Q3 2023

Nov 03, 2023

BUY
$218.65 - $271.46 $3,061 - $3,800
14 Added 0.73%
1,932 $519,000
Q2 2023

Jul 26, 2023

BUY
$214.27 - $253.37 $3,642 - $4,307
17 Added 0.89%
1,918 $425,000
Q1 2023

Apr 19, 2023

BUY
$225.79 - $275.2 $3,612 - $4,403
16 Added 0.85%
1,901 $459,000
Q4 2022

Jan 26, 2023

BUY
$229.03 - $291.01 $2,748 - $3,492
12 Added 0.64%
1,885 $0
Q3 2022

Oct 14, 2022

BUY
$224.46 - $253.15 $3,142 - $3,544
14 Added 0.75%
1,873 $422,000
Q2 2022

Jul 13, 2022

BUY
$230.71 - $256.74 $2,999 - $3,337
13 Added 0.7%
1,859 $452,000
Q1 2022

Apr 28, 2022

BUY
$219.27 - $242.57 $3,069 - $3,395
14 Added 0.76%
1,846 $446,000
Q4 2021

Jan 14, 2022

BUY
$198.88 - $227.6 $2,784 - $3,186
14 Added 0.77%
1,832 $412,000
Q3 2021

Oct 22, 2021

BUY
$212.27 - $248.7 $2,759 - $3,233
13 Added 0.72%
1,818 $386,000
Q2 2021

Jul 21, 2021

BUY
$233.58 - $259.14 $2,802 - $3,109
12 Added 0.67%
1,805 $440,000
Q1 2021

Apr 28, 2021

BUY
$221.91 - $258.6 $2,662 - $3,103
12 Added 0.67%
1,793 $446,000
Q4 2020

Jan 13, 2021

SELL
$216.38 - $257.67 $4,327 - $5,153
-20 Reduced 1.11%
1,781 $424,000
Q3 2020

Oct 16, 2020

BUY
$234.65 - $260.95 $11,732 - $13,047
50 Added 2.86%
1,801 $201,000
Q2 2020

Jul 07, 2020

BUY
$197.81 - $242.74 $2,175 - $2,670
11 Added 0.63%
1,751 $413,000
Q1 2020

Apr 27, 2020

BUY
$182.24 - $241.7 $2,369 - $3,142
13 Added 0.75%
1,740 $352,000
Q4 2019

Jan 09, 2020

BUY
$189.21 - $243.2 $1,892 - $2,432
10 Added 0.58%
1,727 $416,000
Q3 2019

Oct 15, 2019

BUY
$174.11 - $208.62 $1,915 - $2,294
11 Added 0.64%
1,717 $332,000
Q2 2019

Jul 30, 2019

BUY
$166.7 - $195.41 $2,167 - $2,540
13 Added 0.77%
1,706 $314,000
Q1 2019

Apr 30, 2019

BUY
$180.87 - $203.88 $2,170 - $2,446
12 Added 0.71%
1,693 $321,000
Q4 2018

Feb 06, 2019

BUY
$178.4 - $208.25 $1,784 - $2,082
10 Added 0.6%
1,681 $327,000
Q4 2017

Feb 12, 2018

BUY
$168.79 - $188.59 $282,048 - $315,133
1,671
1,671 $289,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $167B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Santori & Peters, Inc. Portfolio

Follow Santori & Peters, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Santori & Peters, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Santori & Peters, Inc. with notifications on news.